Back to All Events

All Things IOP: Updates in Modern Glaucoma Care

 
 

This course explores the evolving understanding of intraocular pressure and its role in glaucoma progression. Attendees will review the clinical significance of corneal hysteresis, IOP fluctuations, and home monitoring technologies, examining how these factors influence treatment decisions. Participants will assess the limitations of current monitoring strategies and explore emerging technologies that support earlier detection, improved risk analysis, and personalized glaucoma care.

Almost 1700 attended our event and we received amazing feedback!

Feedback from anonymous survey:

  • Another great presentation by Dr. Lighthizer. Thank you!

  • Clear, clean presentation of concepts and logic - good job!

  • Always looking forward to Dr. Lighthizer! Another excellent presentation. Thank you!

  • Learned so much. Such an effective speaker. Thanks Dr Lighthizer!

  • A very useful and important clinical topic backed up by research results. On one of the CH studies with an "n" value of 150 subjects, it was not that high as the study participants were split in about 3 groups.

  • Always love listening to Dr Lighthizer speak. Very informative and extremely well presented, as always.

  • Great content and I am definitely going to be looking into some new equipment that was mentioned. I really would like to elevate patient care in regards to glaucoma in our office.

  • I may get certified this speaker kept it simple and plain.

  • Great talk about corneal hysteresis!

Speaker: Nathan Lighthizer, OD

Moderator: Dr. Carolyn Majcher

COPE ID: 107420-GL

Category: Glaucoma

This event is COPE approved for 1 hour of CE credit.

Thank you to iCare | Visionix for sponsoring this event.

iCare | Visionix is an advanced ophthalmic technology company and trusted partner in ocular disease management offering medical devices for retinal imaging, perimetry, tonometry, OCT, refraction, and screening.

Previous
Previous
October 26

Beyond Drops: Underutilized Therapies for Dry Eye Disease

Next
Next
November 4

Reaching for Serum Sooner Part 2: A Deeper Dive into Patient Selection and Clinical Impact